Last reviewed · How we verify
NCT05460052: NARCOSPORT
Evaluation of the Effectiveness of a Physical Activity Program on the Severity of Narcolepsy
trial testing Physical activity training program in Narcolepsy Type 1 in 30 participants. Completed in 24 November 2023.
24 November 2023
Quick facts
| Lead sponsor | Hospices Civils de Lyon |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 30 |
| Start date | 26 August 2022 |
| Primary completion | 24 November 2023 |
| Estimated completion | 24 November 2023 |
| Sites | 1 location across France |
Drugs / interventions tested
- Physical activity training program
- Weekly phone call.
- Personalized training plan.
Conditions studied
- Narcolepsy Type 1 — all drugs for Narcolepsy Type 1 →
Sponsor
Hospices Civils de Lyon — full company profile →
Who can join
Adults 18 to 65, any sex, with Narcolepsy Type 1. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Narcolepsy Type 1 (NT1) is a rare chronic neurological disorder resulting from the selective loss of hypocretin neurons. Patients with NT1 suffer from excessive daytime sleepiness, disrupted nighttime sleep, and cataplexy (emotionally triggered episodes of muscle atonia). The disease is associated with numerous comorbidities such as obesity, metabolic disorders, anxiety-depressive disorders, and attentional disorders, all of which have a strong impact on quality of life.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Feasibility and efficacy of exercise training on sleep symptoms and comorbidities in narcolepsy type 1: a prospective interventional study.
Ricordeau F, Stauffer E, Putois B, Jaffiol A, et al · · 2026 · cited 1× · PMID 40928141 · DOI 10.1093/sleep/zsaf272
Verify or expand the search:
- PubMed search for NCT05460052
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Narcolepsy Type 1
Currently open trials in the same condition.
- NCT07365566 — Pain Assessment in Patients With Idiopathic REM Sleep Behaviour Disorder · NA · recruiting
- NCT07299097 — Epidemiology of Narcolepsy Type 1 and Type 2 in Spain · recruiting
- NCT07096674 — A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia · Phase 2 · recruiting
- NCT06457945 — Mind-wandering and Predictive Processes in Narcolepsy: a Putative Mechanism Through Covert REM Intrusions · NA · recruiting
- NCT06484348 — Deciphering the Interactions Between Food Intake, Sleepiness, and Nighttime Sleep Quality in Patients With Type 1 Narcol · NA · recruiting
Other Hospices Civils de Lyon trials
Trials by the same sponsor.
- NCT07569536 — Efficacy of the Alpha 2 Agonist Dexmedetomidine for Sympathetic Deactivation in REfractory Septic Shock · Phase 3 · not yet recruiting
- NCT07529314 — Evaluating Interventional Radiology for Cancer Pain Management · NA · not yet recruiting
- NCT07273929 — Comparative Study of the Effectiveness of Three Access Routes for Implanting an Electronic Intracardiac Device · Phase 3 · not yet recruiting
- NCT07474532 — Attitudes and Beliefs Related to Benzodiazepine Deprescribing · not yet recruiting
- NCT07313007 — Assessment of Gut Microbiota-Derived Amino Acid Metabolite Production in Patients With MASLD · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05460052 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hospices Civils de Lyon
- Last refreshed: 10 January 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05460052.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing